Satiate Agri (524546)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter sales of ₹6 crore against a ₹6 crore market cap gives a very low price-to-sales ratio (roughly 0.25x annualised), which can be attractive if margins ever stabilise.
• The stock has corrected from ₹41.00 to ₹22.89, sitting near the bottom of its 52-week range; a lot of bad news may already be in the price.
• A small market cap means even a modest absolute profit can create meaningful per-share upside if operations are restructured.

Concerns

• P/E of 0.00 and net profit of ₹-0 crore confirm the latest quarter produced no real earnings for shareholders.
• ROCE of -46.05% and Piotroski F-Score of 2/9 point to severe operational inefficiency and weak financial health.
• Sales growth and profit growth are both 0.00%, and no dividend is paid, so there is no evidence of compounding.
• Book value, debt/equity, and promoter holding are N/A; insufficient disclosure prevents any margin-of-safety calculation.

AI Analysis

Reading Satiate Agri reminds me of why I keep a list of things not to do. A company with a micro-market cap of ₹6 crore, zero or negative earnings, and a Piotroski F-Score of 2/9 has no place in a Graham portfolio. The name suggests agriculture while the industry is pharmaceuticals; I don't bet on stories I cannot understand. The P/E is 0.00 because there is no profit—latest quarter net profit is essentially ₹-0 crore on ₹6 crore sales. Annual sales growth is 0.00%, and profit growth is 0.00%. Without growth, no dividend, and no promoter holding disclosed, what is the owner earning? Nothing. The reported ROE of 37,181.82% is a mathematical illusion from a tiny equity base, not a sign of a wonderful business. ROCE is -46.05%, so the company is destroying capital, not compounding it. At ₹22.89, the stock trades near the bottom of its 52-week range of ₹22.10 to ₹41.00, but a low price is not the same as value. Benjamin Graham said price is what you pay, value is what you get. Here, I cannot calculate value because book value, debt/equity, and promoter holdings are N/A. The FairStock score is insufficient data. If I cannot measure the asset base or earnings power, I cannot have margin of safety. The only positive is quarterly sales of ₹6 crore against a ₹6 crore market cap, which could be interesting if margins ever appear. But with negative ROCE, F-Score 2/9, and no earnings, this is not a business I would ever call an investment. I would pass and wait for a company with earnings, balance sheet clarity, and a moat.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer